Perception Prognosis, Goals of Treatment, and Communication

Completed

• Conditions: Gastric Cancer; Esophageal Cancer; Pancreatic Cancer; Biliary Cancer; Liver Cancer

• Registration Number: NCT01401894
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients understand their illness and goals of treatment and help us improve communication with their doctors. This research is being done because there is not a lot of information on how much patients understand about their illness and prognosis.

Detailed Description

* Participants will be asked to answer a few basic questions regarding race, ethnicity, religion, relationship status, education, income, and living situation.

* They will then be asked to complete a questionnaire which contains questions about their mood, spirituality, quality of life and their understanding of their treatment and prognosis and their communication with their oncologist. They will complete these questionnaires in the clinic or infusion room on one of their regularly scheduled visit.

Study Timeline

• Study Start: 2010-10
• Study First Submitted: 2011-07-20
• Study First Submitted QC: 2011-07-22
• Study First Posted: 2011-07-25
• Primary Completion: 2012-10
• Study Completion: 2014-06
• Status Verified: 2017-01
• Last Update Submitted: 2017-01-28
• Last Update Posted: 2017-01-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Confirmed new diagnosis of advanced gastric, esophageal, pancreatic, and hepatobiliary cancer, not being treated with curative intent.
• Planning to receive chemotherapy at Massachusetts General Hospital
• Ability to read and respond to questions in English.

Exclusion Criteria

• Prior chemotherapy for current stage of disease.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Completion of surveys	1 year

Secondary Outcome Measures

Name	Time	Method
Quality of end of life care	1 year
Survival	1 year
Patients perceptions of prognosis, goals of care, and communication with providers	1 year

Trial Locations

Locations (1)

Massachusetts General Hospital; 🇺🇸 Boston, Massachusetts, United States